Context Therapeutics, Inc. (CNTX)
2.26
-0.17
(-7.00%)
USD |
NASDAQ |
Apr 20, 16:00
2.25
-0.01
(-0.44%)
After-Hours: 20:00
Context Therapeutics Market Cap : 207.65M for April 20, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| ACADIA Pharmaceuticals, Inc. | 3.766B |
| Alnylam Pharmaceuticals, Inc. | 41.24B |
| Savara, Inc. | 1.148B |
| BioMarin Pharmaceutical, Inc. | 10.55B |
| Imunon, Inc. | 6.578M |
Market Cap Related Metrics
| Price to Book Value | 3.434 |
| Price | 2.26 |
| Earnings Yield | -17.01% |